{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:58:37Z","timestamp":1775059117214,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,19]]},"DOI":"10.7759\/cureus.101818","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:17:51Z","timestamp":1768810671000},"source":"Crossref","is-referenced-by-count":1,"title":["Postmortem Serum Prostate-Specific Antigen as a Potential Marker for Prostatic Disease: A Forensic Exploratory Study"],"prefix":"10.7759","author":[{"given":"Sari","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shojiro","family":"Takasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey TA","year":"1987","unstructured":"Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987, 317:909-16. 10.1056\/NEJM198710083171501","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04039.x","article-title":"Histological variants of prostatic carcinoma and their significance","volume":"60","author":"Humphrey PA","year":"2012","unstructured":"Humphrey PA. Histological variants of prostatic carcinoma and their significance. Histopathology. 2012, 60:59-74. 10.1111\/j.1365-2559.2011.04039.x","journal-title":"Histopathology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/wfs2.1363","article-title":"The characteristics of seminal fluid and the forensic tests available to identify it","volume":"2","author":"Gamblin AP","year":"2020","unstructured":"Gamblin AP, Morgan-Smith R. The characteristics of seminal fluid and the forensic tests available to identify it. WIREs Forensic Sci. 2020, 2:e1363. 10.1002\/wfs2.1363","journal-title":"WIREs Forensic Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.12791","article-title":"The stability of prostate-specific antigen in semen under various temperatures","volume":"60","author":"Srettabunjong S","year":"2015","unstructured":"Srettabunjong S, Betset P, Limawongpranee S, Ekpo P. The stability of prostate-specific antigen in semen under various temperatures. J Forensic Sci. 2015, 60:1577-81. 10.1111\/1556-4029.12791","journal-title":"J Forensic Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2009.04.002","article-title":"Positive prostate-specific antigen (PSA) reaction in post-mortem rectal swabs: a cautionary note","volume":"16","author":"Lunetta P","year":"2009","unstructured":"Lunetta P, Sippel H. Positive prostate-specific antigen (PSA) reaction in post-mortem rectal swabs: a cautionary note. J Forensic Leg Med. 2009, 16:397-9. 10.1016\/j.jflm.2009.04.002","journal-title":"J Forensic Leg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/2050312120958212","article-title":"Relationship between serum prostate-specific antigen and age in cadavers","volume":"8","author":"Tsuboi H","year":"2020","unstructured":"Tsuboi H, Miyamori D, Ishikawa N, Ichioka H, Ikegaya H. Relationship between serum prostate-specific antigen and age in cadavers. SAGE Open Med. 2020, 8:2050312120958212. 10.1177\/2050312120958212","journal-title":"SAGE Open Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level \u22644.0 ng per milliliter","volume":"350","author":"Thompson IM","year":"2004","unstructured":"Thompson IM, Pauler DK, Goodman PJ, et al.. Prevalence of prostate cancer among men with a prostate-specific antigen level \u22644.0 ng per milliliter. N Engl J Med. 2004, 350:2239-46. 10.1056\/NEJMoa031918","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1992.03480160073037","article-title":"Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease","volume":"267","author":"Carter HB","year":"1992","unstructured":"Carter HB, Pearson JD, Metter EJ, et al.. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA. 1992, 267:2215-20.","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2351","article-title":"Prostate-specific antigen and prostate cancer: prediction, detection and monitoring","volume":"8","author":"Lilja H","year":"2008","unstructured":"Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer. 2008, 8:268-78. 10.1038\/nrc2351","journal-title":"Nat Rev Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of prostate-specific antigen","volume":"21","author":"Balk SP","year":"2003","unstructured":"Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol. 2003, 21:383-91. 10.1200\/JCO.2003.02.083","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona WJ","year":"1991","unstructured":"Catalona WJ, Smith DS, Ratliff TL, et al.. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991, 324:1156-61. 10.1056\/NEJM199104253241702","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2009.05.012","article-title":"Regulation of matrix contraction in chronic venous disease","volume":"38","author":"Pappas PJ","year":"2009","unstructured":"Pappas PJ, Lal BK, Ohara N, Saito S, Zapiach L, Dur\u00e1n WN. Regulation of matrix contraction in chronic venous disease. Eur J Vasc Endovasc Surg. 2009, 38:518-29. 10.1016\/j.ejvs.2009.05.012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920701)70:1+<225::AID-CNCR2820701309>3.0.CO;2-V","article-title":"Tumor markers in prostate cancer","volume":"70","author":"Cooper EH","year":"1992","unstructured":"Cooper EH, Robinson MR, Whelan P, Ferro MA. Tumor markers in prostate cancer. Cancer. 1992, 70:225-9. 10.1002\/1097-0142(19920701)70:1+&lt;225::AID-CNCR2820701309&gt;3.0.CO;2-V","journal-title":"Cancer"},{"key":"ref14","article-title":"Prostate-specific antigen","author":"David MK","year":"2024","unstructured":"David MK, Leslie SW. Prostate-specific antigen. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000128","article-title":"Serum markers in prostate cancer detection","volume":"25","author":"Bratt O","year":"2015","unstructured":"Bratt O, Lilja H. Serum markers in prostate cancer detection. Curr Opin Urol. 2015, 25:59-64. 10.1097\/MOU.0000000000000128","journal-title":"Curr Opin Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000001308","article-title":"Blood- and urine-based biomarkers for the detection of clinically significant prostate cancer: a contemporary review","volume":"35","author":"Assani KD","year":"2025","unstructured":"Assani KD, Pierce JM, Galloway LA, Tosoian JJ. Blood- and urine-based biomarkers for the detection of clinically significant prostate cancer: a contemporary review. Curr Opin Urol. 2025, 35:590-6. 10.1097\/MOU.0000000000001308","journal-title":"Curr Opin Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003180","article-title":"Beyond PSA: the next generation of prostate cancer biomarkers","volume":"4","author":"Prensner JR","year":"2012","unstructured":"Prensner JR, Rubin MA, Wei JT, Chinnaiyan AM. Beyond PSA: the next generation of prostate cancer biomarkers. Sci Transl Med. 2012, 4:127rv3. 10.1126\/scitranslmed.3003180","journal-title":"Sci Transl Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199805000-00051","article-title":"Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia","volume":"159","author":"Paus E","year":"1998","unstructured":"Paus E, Nilsson O, B\u00f8rmer OP, Foss\u00e5 SD, Otnes B, Skovlund E. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia. J Urol. 1998, 159:1599-605. 10.1097\/00005392-199805000-00051","journal-title":"J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451203-postmortem-serum-prostate-specific-antigen-as-a-potential-marker-for-prostatic-disease-a-forensic-exploratory-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:17:53Z","timestamp":1768810673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451203-postmortem-serum-prostate-specific-antigen-as-a-potential-marker-for-prostatic-disease-a-forensic-exploratory-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.101818","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}